Posts Tagged ‘medication’
AARDEX Group and AdhereTech Partnership Boosts Medication Adherence with Software, Data Analytics and Smart Pill Bottle
Partnership to Enhance Understanding of Patient Behavior and Opportunities for Early Intervention
Read MoreExamining the Role of Data Science in Understanding Patient Behaviors.
Our latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior.
Read MoreAARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
Read MoreOur latest article in PMPS discusses how non-adherence to medication has been costing lives and money for decades but SmartPackaging solutions are now solving the age-old problem.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 46-49. © Samedan Ltd
Read MoreAARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
Read MoreA Digital Innovation for the Personalized Management of Adherence
Bernard Vrijens our CEO and Scientific Lead, and Anna-Elisa Hein realizing a master thesis placement at AARDEX Group, conducted a study analyzing the strengths, weaknesses, threats, and opportunities of digital innovation for the personalized management of medication adherence. Anna-Elisa interviewed different experts as part of her master thesis. The study aims to show that a…
Read MoreWe see an uptake in Remote, Decentralized and Hybrid Trials. Do you?
We are soon leaving a very difficult year in all aspects. We lived with global pandemic and civil troubles in the news all year long. However, our Scientific Lead, Bernard Vrijens sees an uptake in remote, decentralized, and hybrid trials. Because humans will always learn, and innovate from difficulties. That’s exactly what PharmaVoice magazine tried…
Read MoreONdrugDelivery October Issue is now live which includes a contribution of AARDEX Group
AARDEX’s Scientific Lead Bernard Vrijens and Biocorp’s business development director Arnaud Guillet give some details about their companies alliance. They explain how Biocorp’s Injay connected prefilled syringe (PFS) combined with AARDEX’s MEMS Adherence Software provides a mean to tackle the issue of medication non-adherence in both clinical trials and commercialized drug products. Low adherence to…
Read MoreThe Contract Pharma October Issue is now live which includes an article about AARDEX Group
Medication adherence, which involves patients taking medications in accordance with how they have been prescribed, is a widespread challenge, with wide-reaching implications for patients and health services worldwide. Managing patient compliance can make the difference between failed and successful clinical trials. Advanced digital medication adherence monitoring using electronically-enabled smart packages or devices offers numerous benefits…
Read MoreAARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices.
Read More